Arteriosclerosis
Not yet recruitingStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
- Disease:Arteriosclerosis
- Substances:–
Germany- Participants:18–64 years · 65+ years
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany19 clinical trials in Detmold, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Investigating treatment options for Actinic Keratosis on face and scalp, focusing on comparative effectiveness of topical treatments for preventing skin cancer development.
Long-term safety evaluation of innovative topical therapies.
Research focusing on treating Post-COVID Syndrome, examining inflammatory response reduction and physical function improvement.
Novel therapeutic approaches for long-term COVID effects.
Evaluating tranexamic acid use in major abdominal surgeries to reduce blood loss and transfusion requirements.
Advancing surgical outcomes in complex procedures.
Multiple studies focusing on cancer treatment optimization, including colon cancer, ovarian cancer, and endometrial cancer management.
Personalized treatment approaches based on genetic markers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.